| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 4.40× | 4.40× | 8.19× | 12.31× | 15.84× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 0.66× | 0.66× | 0.71× | 0.71× | 0.58× | ||
| 24.88× | 24.88× | 8.57× | 4.32× | 0.48× | ||
| 13.42× | 13.42× | 5.24× | 4.71× | 3.23× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 15.84 | 12.31 | 8.19 | 4.40 | 4.40 | |
| Asset Turnover | 0.58 | 0.71 | 0.71 | 0.66 | 0.66 | |
| Cash Conversion (CFO/Net Income) | 0.48 | 4.32 | 8.57 | 24.88 | 24.88 | |
| CFO/EBITDA | 3.23 | 4.71 | 5.24 | 13.42 | 13.42 |